CJC-1295 No DAC 5 mg + Ipamorelin 5 mg

CJC-1295 No DAC 5 mg + Ipamorelin 5 mg is a dual-peptide formulation designed for growth hormone and endocrine signaling research, combining two research peptides with distinct receptor-related mechanisms.

CJC-1295 No DAC, commonly used in the research-peptide field to refer to Modified GRF (1-29), is a short-acting GHRH analog investigated for GHRH receptor activation, pituitary function, GH release, and pulsatile growth hormone signaling.

Ipamorelin is a growth-hormone-secretagogue-related research peptide studied for its interaction with the ghrelin receptor/GHS-R1a (Growth Hormone Secretagogue Receptor) and associated pituitary GH-release mechanisms.

Together, the two compounds provide an experimental system for investigating interactions between GHRH receptor and GHS-R1a signaling, including their relationships with pulsatile GH secretion, the GH/IGF-1 axis, and endocrine regulation.

The safety, efficacy, or appropriate human dosing of this specific 5 mg + 5 mg combination cannot be inferred from studies of either component individually and should not be represented as having established muscle-building, fat-loss, anti-aging, or performance-enhancing effects.

La livraison est facturée selon le nombre d'articles de la commande, aux mêmes tarifs pour toutes les destinations, et le montant exact s'affiche au moment du paiement, avant de payer. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.